Jun 15, 2020
Impel NeuroPharma Presents Data From INP104 Clinical Program In Acute Migraine At The 2020 American Headache Society (AHS) Virtual Annual Scientific Meeting
Jun 13, 2020
EHA25Virtual: A Paradigm Shift for the Treatment of Newly Diagnosed Older Acute Myeloid Leukemia Patients
Jun 13, 2020
VENCLEXTA®/VENCLYXTO® (venetoclax) Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve Acute Myeloid Leukemia Patients
May 14, 2020
Tolero Pharmaceuticals Announces Expansion of the Zella 102 Study in Patients with Intermediate and High-Risk Myelodysplastic Syndromes (MDS)
Apr 22, 2020
CStone announces acceptance of its first New Drug Application in mainland China by the National Medical Products Administration, for the first-in-class precision therapy avapritinib in two gastrointestinal stromal tumor indications
Apr 16, 2020
Aging Populations Will Increase Demand in the $35,802 Million Antithrombotic Drugs Market, Reports TBRC
Dec 10, 2019
Small Molecule Oncology Drug Market Forecast to Exceed $66 Billion in 2019
Dec 04, 2019
Trovagene Announces Data Showing Ability of Onvansertib to Rescue Venetoclax-Resistance in Acute Myeloid Leukemia (AML)
Oct 30, 2019
Global Schizophrenia Drugs (Orals & Injectables) Market Insights, Trends and Forecasts, 2013-2018 & 2019-2023
Sep 20, 2019
Astellas Receives Positive CHMP Opinion for XOSPATA® (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
Sep 19, 2019
Lilly Announces Webcast to Discuss ESMO 2019 Presentations
Aug 08, 2019
Correvio to Report Second Quarter 2019 Financial Results
Aug 07, 2019
Portola Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Aug 05, 2019
New findings provide definitive management guidelines for patients on direct oral anticoagulants with atrial fibrillation undergoing elective procedures or surgeries
Jul 05, 2019
Information Update - Multiple sexual enhancement products seized from five stores in Scarborough, Ontario, may pose serious health risks
Jun 11, 2019
Information Update - Multiple unauthorized sexual enhancement supplements seized from Forbidden Pleasures stores in Ontario may pose serious health risks
May 30, 2019
U.S. FDA Approves Supplemental New Drug Application Adding Overall Survival Data for XOSPATA® (gilteritinib)
May 20, 2019
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology
May 07, 2019
Armas Pharmaceuticals Continues to Add to Portfolio With Launch of Second Oncology Injectable
Apr 03, 2019
Correvio Announces Zevtera® Abstracts at ECCMID 2019